Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Rohrbacker Leslie C
2. Date of Event Requiring Statement (Month/Day/Year)
02/09/2010
3. Issuer Name and Ticker or Trading Symbol
MEDICINES CO /DE [MDCO]
(Last)
(First)
(Middle)
8 SYLVAN WAY
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP, Chief Human Strategy Offic
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

PARSIPPANY, NJ 07054
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 3,855 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)   (2) 12/05/2015 Common Stock 20,000 $ 18.65 D  
Option (right to buy)   (3) 02/16/2017 Common Stock 6,052 $ 28.6 D  
Option (right to buy)   (4) 02/15/2018 Common Stock 7,825 $ 19.36 D  
Option (right to buy)   (5) 03/03/2018 Common Stock 20,000 $ 18.39 D  
Option (right to buy)   (6) 02/20/2019 Common Stock 2,956 $ 13.95 D  
Option (right to buy)   (7) 06/01/2019 Common Stock 10,000 $ 7.61 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Rohrbacker Leslie C
8 SYLVAN WAY
PARSIPPANY, NJ 07054
      VP, Chief Human Strategy Offic  

Signatures

/s/Leslie C. Rohrbacker 02/17/2010
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) As of 2/9/2010 the shares of restricted stock (3,855 granted on 2/20/2009) were not vested. The shares vest 25% annually ending 2/20/2013.
(2) As of 2/9/2010, the original grant (25,000 granted on 12/5/2005) was fully vested with 5,000 options having been exercised.
(3) As of 2/9/2010, the original grant (6,052 granted on 2/16/2007) was vested with respect to 4,413 of the shares covered thereby, none of which options have been exercised. The remaining 1,639 shares covered by this option vest in equal monthly installments ending 2/16/2011.
(4) As of 2/9/2010, the orginal grant (7,825 granted on 2/15/2008) was vested with respect to 3,749 of the shares covered thereby, none of which options have been exercised. The remaining 4,076 shares covered by this option vest in equal monthly installments ending on 2/15/2012.
(5) As of 2/9/2010, the original grant (20,000 granted on 3/3/2008) was vested with respect to 9,583 of the shares covered thereby, none of which options have been exercised. The remaining 10,417 shares covered by this option vest in equal monthly installments ending on 3/3/2012.
(6) As of 2/9/2010, the original grant (2,956 granted on 2/20/2009) was vested with respect to 677 of the shares covered thereby, none of which options have been exercised. The remaining 2,279 shares covered by this option vest in equal monthly installments ending 2/20/2013.
(7) As of 2/9/2010, the original grant (10,000 granted on 6/1/2009) was vested with respect to 1,667 of the shares covered thereby, none of which options have been exercised. The remaining 8,333 shares covered by this option vest in equal monthly installments ending on 6/1/2013.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.